Key terms

About GNPX

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest GNPX news

Apr 03 8:37am ET Genprex expands clinical trial sites for study of Reqorsa in lung cancer by TipRanks Apr 03 6:40am ET Analysts Offer Insights on Healthcare Companies: Evaxion Biotech (EVAX), Genprex (GNPX) and 60 Degrees Pharmaceuticals, Inc. (SXTP) by TipRanks Apr 03 6:31am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Evaxion Biotech (EVAX), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Genprex (GNPX) by TipRanks Mar 25 6:20am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Mar 25 6:11am ET Genprex initiated with a Buy at H.C. Wainwright by TipRanks Mar 19 1:27pm ET Genprex announces $6.5M registered direct offering priced at the market by TipRanks Mar 19 8:56am ET Genprex to sell 1.54M shares at $4.215 in registered direct offering priced ATM by TipRanks Mar 19 8:39am ET Genprex to sell 1.54M shares at $4.215 per share by TipRanks Mar 12 9:02am ET Genprex receives Notice of Patent Grant for Korean patent by TipRanks Feb 07 11:01am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 07 8:19am ET Genprex expands nonclinical programs to study TUSC2 by TipRanks Feb 06 4:23am ET Genprex Launches Phase 2a Reqorsa Trial Expansion by TipRanks Feb 05 7:36am ET Genprex: First person dosed in Phase 2a expansion of Acclaim-1 trial by TipRanks Feb 02 11:07am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 01 7:50pm ET Genprex trading halted, news pending by TipRanks Feb 01 11:24am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 31 8:43am ET Genprex announces 1-for-40 reverse split by TipRanks

No recent press releases are available for GNPX

GNPX Financials

1-year income & revenue

Key terms

GNPX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

GNPX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming